D
First Tracks Biotherapeutics, Inc. TRAX
$44.04 $0.010.02% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 06/30/2025
Total Cash And Short-Term Investments 168.02M 286.46M --
Total Receivables 5.07M -- --
Inventory -- -- --
Prepaid Expenses -- 2.95M --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets 4.65M -- --
Total Current Assets 177.75M 289.40M --

Total Current Assets 177.75M 289.40M --
Net Property, Plant & Equipment 5.40M 1.17M --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- --
Total Assets 183.14M 290.58M --

Total Accounts Payable 2.55M 7.50M --
Total Accrued Expenses 7.46M 25.62M --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current 2.44M -- --
Total Finance Division Other Current Liabilities -- -- --
Total Other Current Liabilities -- -- --
Total Current Liabilities 12.45M 33.11M --

Total Current Liabilities 12.45M 33.11M --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases 1.90M -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- --
Total Liabilities 14.34M 33.11M --

Common Stock & APIC 193.37M 257.61M --
Retained Earnings -24.58M -- --
Treasury Stock & Other -- -146.00K --
Total Common Equity 168.80M 257.46M --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity 168.80M 257.46M --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity 168.80M 257.46M --